Home Featured Page 269

Featured

Latest

Australia’s Psychedelic Experiment: Progress, Pitfalls, and What Comes Next

Views from the Field on Psychedelics in 2026: Excitement, Anxiety, and Open Questions

Op-Ed: Psychedelics in Practice: What the State Programs Are Teaching Us

The Psychedelic News Feed: January 05 – 11, 2026

From Brussels to the Ballot: How PsychedeliCare Took Psychedelic Therapy to the European Public

4 Ways to Help Destigmatize Psychedelic Therapy in the Black Community

Study Suggests Beneficial Effects of Psilocybin Are Independent of 5-HT2A

Psyched Wellness Receives DTC Eligibility

GH Research Announces Closing of $125 Million Oversubscribed Series B Financing

Red Light Holland Enters into Letter of Intent to Acquire Controlling...

Using a Casing Layer for Growing Magic Mushrooms – Why Bother?

Mydecine Announces Launch of Cutting-Edge Therapeutic Compound Screening

Cybin Advances IND-Enabling Studies of Two Psychedelic Molecules, CYB003 and CYB004...

Former GW Pharmaceuticals CFO joins Beckley Psytech’s Board

PT239 – Richie Ogulnick – Ibogaine, Unicity, and Beneficence

1...268269270...306 Page 269 of 306

Australia’s Psychedelic Experiment: Progress, Pitfalls, and What Comes Next

Views from the Field on Psychedelics in 2026: Excitement, Anxiety, and...

Op-Ed: Psychedelics in Practice: What the State Programs Are Teaching Us

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Australia’s Psychedelic Experiment: Progress, Pitfalls, and What Comes Next

Views from the Field on Psychedelics in 2026: Excitement, Anxiety, and Open Questions

Op-Ed: Psychedelics in Practice: What the State Programs Are Teaching Us

The Psychedelic News Feed: January 05 – 11, 2026

From Brussels to the Ballot: How PsychedeliCare Took Psychedelic Therapy to the European Public

4 Ways to Help Destigmatize Psychedelic Therapy in the Black Community

Study Suggests Beneficial Effects of Psilocybin Are Independent of 5-HT2A

Psyched Wellness Receives DTC Eligibility

GH Research Announces Closing of $125 Million Oversubscribed Series B Financing

Red Light Holland Enters into Letter of Intent to Acquire Controlling...

Using a Casing Layer for Growing Magic Mushrooms – Why Bother?

Mydecine Announces Launch of Cutting-Edge Therapeutic Compound Screening

Cybin Advances IND-Enabling Studies of Two Psychedelic Molecules, CYB003 and CYB004...

Former GW Pharmaceuticals CFO joins Beckley Psytech’s Board

PT239 – Richie Ogulnick – Ibogaine, Unicity, and Beneficence

EDITOR PICKS

Australia’s Psychedelic Experiment: Progress, Pitfalls, and What Comes Next

Views from the Field on Psychedelics in 2026: Excitement, Anxiety, and...

Op-Ed: Psychedelics in Practice: What the State Programs Are Teaching Us

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY